-
Product Insights
NewLikelihood of Approval Analysis for Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
Overview How likely is it that the drugs in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) Overview Post-essential thrombocythemia myelofibrosis...
-
Innovation Ranking
NewInnovation Ranking – Deutsche Post AG
Deutsche Post AG (DPDHL), d/b/a Deutsche Post DHL Group, is a provider of mail and logistics services. It offers logistics services under the brand name, DHL, and postal services under the brand name, Deutsche Post. The company provides national and international mail and parcel services; outsourcing and system solutions; international express; air freight, ocean freight and overland freight forwarding; contract logistics; e-commerce; and supply chain management services. The company also offers dialogue marketing services, press distribution services, and electronic services...
-
Innovation Ranking
NewInnovation Ranking – Poste Italiane Group
Poste Italiane SpA (Post Italiane) is a provider of financial and postal products and services. It offers a range of insurance products; mail, parcels and distribution services; and payments, mobile, and digital services to individuals and corporate institutions. The company offers insurance products for life, fire, third-party and general liability, accident and health, among others. It also offers mail, parcels and distribution services such as letter post, parcels and philately, logistics, express delivery, e-money products, and payment and collection services....
-
Innovation Ranking
NewInnovation Ranking – Post Holdings Inc
Post Holdings Inc (Post) manufactures, markets, and distributes branded and private label ready-to-eat cereals, snacks, and active nutrition products. The company’s product portfolio includes egg products, refrigerated potato products, cheese and dairy case products, pasta products, ready-to-drink beverages, bars, powders, nutritional supplements, and nut butters. It also offers baking nuts, dried fruit pasta, and granola. The company markets and sells the products under the Honey Bunches of Oats, Great Grains, Better’n Eggs, Premier Protein, and Dymatize brand names. Post sells...
-
Product Insights
NewLikelihood of Approval Analysis for Post Menopausal Osteoporosis
Overview How likely is it that the drugs in Post Menopausal Osteoporosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Post Menopausal Osteoporosis Overview Postmenopausal osteoporosis is the most common form...
-
Product Insights
NewLikelihood of Approval Analysis for Post-Operative Pain
Overview How likely is it that the drugs in Post-Operative Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Post-Operative Pain Overview Post-operative pain is a common consequence following surgical procedures,...
-
Innovation Ranking
NewInnovation Ranking – Japan Post Holdings Co Ltd
Japan Post Holdings Co Ltd (Japan Post Holdings) is an insurance and postal delivery service provider. The company, along with its subsidiaries, offers postal services such as international mail, express mail service (EMS), Yu-pack, standard mail, postal money order, and postal savings. It also offers stamps and postcards, Japanese government bonds and investment trusts. Furthermore, the company provides life insurance products, savings accounts, and deposit products. Japan Post Holdings distributes its postal, banking and insurance solutions through its network of...
-
Innovation Ranking
NewInnovation Ranking – Japan Post Bank Co Ltd
Japan Post Bank Co Ltd (Japan Post Bank), a subsidiary of Japan Post Holdings Co., Ltd, provides financial services. Its major operations include securities investment, deposit taking, domestic and foreign exchange, syndicated loans and lending, asset management, and sales of government bonds and investment trusts and insurance. The bank also provides cash withdrawal services for credit cards, financing and cash cards issued by overseas financial institutions. Its cards include VISA, MasterCard, JCB and Yucho Pay. Japan Post Bank also provides...
-
Product Insights
NewLikelihood of Approval Analysis for Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Overview How likely is it that the drugs in Post-Polycythemia Vera Myelofibrosis (PPV-MF) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Overview Post-polycythemia vera myelofibrosis (PPV-MF) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Elotuzumab in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Elotuzumab in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Elotuzumab in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) Drug Details:...